Report Detail

Other Global Long Acting Insulins Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3624853
  • |
  • 26 July, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.

Scope of the Report:
The global Long Acting Insulins market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Long Acting Insulins.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Long Acting Insulins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Long Acting Insulins market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novo Nordisk
Sanofi
Wockhardt UK

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin

Market Segment by Applications, can be divided into
Home Use
Medical Institutions
Others


Table of Contents

    1 Long Acting Insulins Market Overview

    • 1.1 Product Overview and Scope of Long Acting Insulins
    • 1.2 Classification of Long Acting Insulins by Types
      • 1.2.1 Global Long Acting Insulins Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Long Acting Insulins Revenue Market Share by Types in 2018
      • 1.2.3 Insulin Glargine
      • 1.2.4 Insulin Determir
      • 1.2.5 Insulin Degludec
      • 1.2.6 Long Acting Animal Insulin
    • 1.3 Global Long Acting Insulins Market by Application
      • 1.3.1 Global Long Acting Insulins Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Home Use
      • 1.3.3 Medical Institutions
      • 1.3.4 Others
    • 1.4 Global Long Acting Insulins Market by Regions
      • 1.4.1 Global Long Acting Insulins Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Long Acting Insulins Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Long Acting Insulins Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Long Acting Insulins Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Long Acting Insulins Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Long Acting Insulins Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Long Acting Insulins (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Novo Nordisk
      • 2.1.1 Business Overview
      • 2.1.2 Long Acting Insulins Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 Long Acting Insulins Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Wockhardt UK
      • 2.3.1 Business Overview
      • 2.3.2 Long Acting Insulins Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Long Acting Insulins Market Competition, by Players

    • 3.1 Global Long Acting Insulins Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Long Acting Insulins Players Market Share
      • 3.2.2 Top 10 Long Acting Insulins Players Market Share
    • 3.3 Market Competition Trend

    4 Global Long Acting Insulins Market Size by Regions

    • 4.1 Global Long Acting Insulins Revenue and Market Share by Regions
    • 4.2 North America Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 4.5 South America Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)

    5 North America Long Acting Insulins Revenue by Countries

    • 5.1 North America Long Acting Insulins Revenue by Countries (2014-2019)
    • 5.2 USA Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Long Acting Insulins Revenue and Growth Rate (2014-2019)

    6 Europe Long Acting Insulins Revenue by Countries

    • 6.1 Europe Long Acting Insulins Revenue by Countries (2014-2019)
    • 6.2 Germany Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 6.3 UK Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 6.4 France Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Long Acting Insulins Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Long Acting Insulins Revenue by Countries

    • 7.1 Asia-Pacific Long Acting Insulins Revenue by Countries (2014-2019)
    • 7.2 China Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 7.5 India Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Long Acting Insulins Revenue and Growth Rate (2014-2019)

    8 South America Long Acting Insulins Revenue by Countries

    • 8.1 South America Long Acting Insulins Revenue by Countries (2014-2019)
    • 8.2 Brazil Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Long Acting Insulins Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Long Acting Insulins by Countries

    • 9.1 Middle East and Africa Long Acting Insulins Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Long Acting Insulins Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Long Acting Insulins Revenue and Growth Rate (2014-2019)

    10 Global Long Acting Insulins Market Segment by Type

    • 10.1 Global Long Acting Insulins Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Long Acting Insulins Market Forecast by Type (2019-2024)
    • 10.3 Insulin Glargine Revenue Growth Rate (2014-2024)
    • 10.4 Insulin Determir Revenue Growth Rate (2014-2024)
    • 10.5 Insulin Degludec Revenue Growth Rate (2014-2024)
    • 10.6 Long Acting Animal Insulin Revenue Growth Rate (2014-2024)

    11 Global Long Acting Insulins Market Segment by Application

    • 11.1 Global Long Acting Insulins Revenue Market Share by Application (2014-2019)
    • 11.2 Long Acting Insulins Market Forecast by Application (2019-2024)
    • 11.3 Home Use Revenue Growth (2014-2019)
    • 11.4 Medical Institutions Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Long Acting Insulins Market Size Forecast (2019-2024)

    • 12.1 Global Long Acting Insulins Market Size Forecast (2019-2024)
    • 12.2 Global Long Acting Insulins Market Forecast by Regions (2019-2024)
    • 12.3 North America Long Acting Insulins Revenue Market Forecast (2019-2024)
    • 12.4 Europe Long Acting Insulins Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Long Acting Insulins Revenue Market Forecast (2019-2024)
    • 12.6 South America Long Acting Insulins Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Long Acting Insulins Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Long Acting Insulins. Industry analysis & Market Report on Long Acting Insulins is a syndicated market report, published as Global Long Acting Insulins Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Long Acting Insulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,742.24
      4,113.36
      5,484.48
      3,201.60
      4,802.40
      6,403.20
      541,488.00
      812,232.00
      1,082,976.00
      290,162.40
      435,243.60
      580,324.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report